84 related articles for article (PubMed ID: 4079592)
1. Edemagenic activity of aqueous form of muramyl dipeptide (MDP) in rats.
Zídek Z; Masek K
Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):419-26. PubMed ID: 4079592
[TBL] [Abstract][Full Text] [Related]
2. Differences in proinflammatory activity of several immunomodulatory derivatives of muramyl dipeptide (MDP) with special reference to the mechanism of the MDP effects.
Zídek Z
Agents Actions; 1992 May; 36(1-2):136-45. PubMed ID: 1414682
[TBL] [Abstract][Full Text] [Related]
3. Muramyl dipeptide and sleep in rat.
Kadlecová O; Masek K
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):111-5. PubMed ID: 3713371
[TBL] [Abstract][Full Text] [Related]
4. Some cellular and pathophysiological correlates of the inflammatory effects of a synthetic immunomodulatory agent, muramyl dipeptide (MDP).
Zídek Z; Franková D; Masek K
Agents Actions; 1993 Jan; 38(1-2):106-15. PubMed ID: 8386899
[TBL] [Abstract][Full Text] [Related]
5. Comparative effect of muramyl dipeptide in vivo and in vitro on the tumoricidal activity of rat peritoneal macrophages.
Reisser D; Jeannin JF; Lagadec P; Martin F
J Biol Response Mod; 1985 Oct; 4(5):460-3. PubMed ID: 4078593
[TBL] [Abstract][Full Text] [Related]
6. Analgesic activity of two synthetic immunomodulators, muramyl dipeptide and adamantylamide dipeptide in mice and rats.
Horák P; Masek K
Methods Find Exp Clin Pharmacol; 1988 Sep; 10(9):569-74. PubMed ID: 2976106
[TBL] [Abstract][Full Text] [Related]
7. Influence of indomethacin on various immunopharmacological effects of muramyl dipeptide (MDP).
Parant M; Riveau G; Chedid L
Agents Actions Suppl; 1980; 7():33-40. PubMed ID: 6941684
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of LiCl-induced conditioning of anticipatory nausea in rats following immune system stimulation: comparing the immunogens lipopolysaccharide, muramyl dipeptide, and polyinosinic: polycytidylic acid.
Cloutier CJ; Rodowa MS; Cross-Mellor SK; Chan MY; Kavaliers M; Ossenkopp KP
Physiol Behav; 2012 May; 106(2):243-51. PubMed ID: 22342813
[TBL] [Abstract][Full Text] [Related]
9. Hepatic mixed-function oxidase system and microsomal lipid peroxidation in rats treated with a synthetic immunomodulator, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP).
Yanev S; Zídek Z; Kadiiska M; Serbinova E; Masek K; Stoytchev T
Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):311-5. PubMed ID: 6748821
[TBL] [Abstract][Full Text] [Related]
10. Muramyl dipeptide stimulation of particle clearance in several animal species.
Waters RV; Ferraresi RW
J Reticuloendothel Soc; 1980 Nov; 28(5):457-71. PubMed ID: 7441647
[No Abstract] [Full Text] [Related]
11. Muramyl dipeptide enhances the response to endotoxin to cause multiple organ injury in the anesthetized rat.
Murch O; Abdelrahman M; Kapoor A; Thiemermann C
Shock; 2008 Mar; 29(3):388-94. PubMed ID: 17693945
[TBL] [Abstract][Full Text] [Related]
12. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro].
Reisser D; Jeannin JF; Martin F
C R Seances Acad Sci III; 1982 Nov; 295(8):485-8. PubMed ID: 6819063
[TBL] [Abstract][Full Text] [Related]
13. The protection from hepatotoxicity of some compounds by the synthetic immunomodulator muramyl dipeptide (MDP) in rat hepatocytes and in vivo.
Farghali H; Machková Z; Kameníková L; Jankü I; Masek K
Methods Find Exp Clin Pharmacol; 1984 Aug; 6(8):449-54. PubMed ID: 6492941
[TBL] [Abstract][Full Text] [Related]
14. Improvement of normothermic rat liver ischemia/reperfusion by muramyl dipeptide.
Cursio R; Gugenheim J; Panaia-Ferrari P; Lasfar A; Tovey M; Chastanet S; Saint-Paul MC; Ferré C; Mouiel J
J Surg Res; 1998 Dec; 80(2):339-44. PubMed ID: 9878335
[TBL] [Abstract][Full Text] [Related]
15. The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG).
Campos MM; Henriques MG; Calixto JB
Br J Pharmacol; 1997 Feb; 120(3):502-8. PubMed ID: 9031756
[TBL] [Abstract][Full Text] [Related]
16. Neuroimmune intercommunication, central opioids, and the immune response to bacterial endotoxin.
Dougherty PM; Dafny N
J Neurosci Res; 1988; 19(1):140-8. PubMed ID: 3343705
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of muramyl dipeptide in experimental models of acute inflammation.
Zídek Z; Masek K; Sedivý F
Agents Actions; 1984 Jan; 14(1):72-5. PubMed ID: 6608216
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in the effects of muramyl dipeptide and lipopolysaccharide on locomotor activity and the development of behavioral tolerance in rats.
Engeland CG; Kavaliers M; Ossenkopp KP
Pharmacol Biochem Behav; 2003 Jan; 74(2):433-47. PubMed ID: 12479965
[TBL] [Abstract][Full Text] [Related]
19. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
Sone S; Fidler IJ
J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
